QTc variability in schizophrenia patients treated with antipsychotics and healthy controls

Journal of Clinical Psychopharmacology

Volumn 25, Issue 3, 2005, Pages 206-210

  Rettenbacher, Maria A ^a   Eder Ischia, Ursula ^a   Bader, Angelika ^b   Edlinger, Monika ^a   Hofer, Alex ^a   Hummer, Martina ^a   Kemmler, Georg ^a   Weiss, Elisabeth M ^a   Hochleitner, Monika ^b   Fleischhacker, W Wolfgang ^a  

^a UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; CLOZAPINE; HALOPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; ZOTEPINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 21044450039     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000162799.64378.fc     Document Type: Article

References (32)

1. Moss AJ. Measurement of the QT interval and the risk associated with QTc interval prolongation: a review. Am J Cardiol. 1993;72:23B-25B.
2. De Bruyne MC, Hoes AW, Kors JA, et al. Prolonged QT interval predicts cardiac and all cause mortality in the elderly: the Rotterdam Study. Eur Heart J. 1999;20:278-284.
3. Thomas SHL. QT interval abnormalities and ventricular arrhythmias. Adv Drug React Acute Toxicol Rev. 1994;13:77-102.
4. Vieweg WVR. Mechanisms and risk of electrocardiographic QT interval prolongation when using antipsychotic drugs. J Clin Psychiatry. 2002;63(suppl 9):18-24.
5. Woosley R, Sketch MH. Gender and drug-induced Torsade de Pointes. ACCEL 30, No 2. Bethesda, MD: American College of Cardiology; 1998.
6. Kelly HG, Fay JE, Lavery SG. Thioridazine hydrochloride (Mellaril): its effects on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Can Med Assoc J. 1963;89:546-554.
7. Mehtonen OP, Aranko K, Malkonen L, et al. A survey of sudden death associated with the use of antipsychotic or antidepressant drugs: 49 cases in Finland. Acta Psychiatr Scand. 1991;84:58-64.
8. Glassmann AH, Bigger JT. Antipsychotic drugs: prolonged QTc interval, Torsade de Pointes, and sudden death. Am J Psychiatry. 2001;158:1774-1782.
9. Lemmens P, Brecher M, Van Baelen B. Tolerability and cardiovascular safety of risperidone. Poster presented at the: 6th World Congress of Biological Psychiatry; June 22-27, 1997; Nice, France.
10. Conley RR. Risperidone side effects. J Clin Psychiatry. 2000;61(suppl 8):20-23.
11. Ravin DS, Levenson JW. Fatal cardiac event following initiation of risperidone therapy. Ann Pharmacother. 1997;31:867-870.
12. Yerrabolu M, Prabhudesai S, Tawam M, et al. Effect of risperidone on QT interval and QT dispersion in the elderly. Heart Dis. 2000;2(1):10-12.
13. Kang UG, Kwon JS, Ahn YM, et al. Electrocardiographic abnormalities in patients treated with clozapine. J Clin Psychiatry. 2000;61:441-446.
14. Agelink MW, Majewski T, Wurthmann C, et al. Effects of newer atypical antipsychotics on autonomic neurocardiac function: a comparison between amisulpride, olanzapine, sertindole and clozapine. J Clin Psychopharmacol. 2001;21:8-13.
15. Parsons M, Buckley NA. Overdose of antipsychotic drugs: practical management guidelines. CNS Drugs. 1997;7:427-441.
16. De Ponti F, Poluzzi E, Montanaro N. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience. Eur J Clin Pharmacol. 2000;56(1):1-18.
17. Viskin S. Long QT syndromes and Torsade de Pointes. Lancet. 1999;354:1625-1633.
18. Drolet B, Zhang, S, Deschenes D, et al. Droperidol lengthens cardiac repolarization due to block of the rapid component of the delayed rectified potassium current. J Cardiovasc Electrophysiol. 1999;10:1597-1604.
19. Drolet B, Rousseau G, Daleau P. Pimozide (Orap) prolongs cardiac repolarisation by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes. J Cardiovasc Pharmacol Ther. 2001;6(3):255-260.
20. Miceli JL. IM ziprasidone and IM haloperidol have comparable effects on QTc CMAX. Poster presented at: America Psychiatric Association annual meeting; May 18-23, 2002; Philadelphia, Pa.
21. Harrigan EP, Miceli JJ, Anziano R, et al. A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol. 2004;24:62-69.
22. Morganroth J, Brazovich FV, McDonald JT, et al. Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia. Am J Cardiol. 1991;67:774-776.
23. Buja G, Miorelli M, Turrini P, et al. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol. 1993;72(12):973-976.
24. Woodward MN, Earnshaw JJ, Heather BP. The value of QT dispersion in assessment of cardiac risk in elective aortic aneurysm surgery. Eur J Vasc Endovasc Surg. 1998;15:267-269.
25. Aitchison JD, Campbell RW, Higham PD. Time dependent variability of QT dispersion after acute myocardial infarction and its relation to ventricular fibrillation: a prospective study. Heart. 2000;84:504-508.
26. Kitayama H, Kiuchi K, Nejima J, et al. Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease. Eur J Clin Pharmacol. 1999;55:259-262.
27. Tisdale JE, Rasty S, Padhi ID, et al. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes. J Clin Pharmacol. 2001;41(12):1310-1318.
28. In: Crowder MJ, Hand DJ, eds. Analysis of Repeated Measures. London: Chapman & Hall; 1990.
29. Browne K, Prystowsky E, Heger JJ, et al. Prolongation of the QT interval in man during sleep. Am J Cardiol. 1983;52:55-59.
30. Garson A. How to measure the QT interval: what is normal? Am J Cardiol. 1993;72:14B-16B.
31. Gryglewska B, Grodzicki T, Czarnecka D, et al. QT dispersion and hypertensive heart disease in the elderly. J Hypertens. April 18, 2002;18(4):461-464.
32. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry. 2002;63(suppl 9):5-11.